The Israeli Trade & Economic Mission in India and Israel Export Institute are organizing an Israeli Medical Device and Health IT Delegation to India. There would be 6 Israeli companies. The tentative dates for B2B are: July 31 in Jaipur, August 2 in New Delhi.
The companies requested to meet Hospitals, Distributors, Importers and Medical Device companies.
|BSP invented a novel, non-invasive and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease. HyperQ technology detects ECG stress induced ischemia and acute ischemia in resting ECG tests|
|G Medical Innovations
|G Medical Innovations (ASX: GMV) is providing next generation mobile health (mHealth) technologies, from initial design through regulatory approvals and commercialization. Offering consumer and professional clinical-grade products including: ‘Prizma’ medical smartphone case, turning consumers’ smartphone into a mobile medical health monitoring solution, and the G Medical Patch (GMP), a real-time patient continuous monitoring solution that automatically presents data in a call center (IDTF) or hospital setting.|
|INSIGHTEC, founded in 1999, develops and distributes the Exablate platform which provides non-invasive treatments for a variety of neurosurgery, oncology and gynecology indications. The Exablate platform uses revolutionary MRgFUS technology which combines high intensity focused ultrasound guided by Magnetic Resonance Imaging (MRI). Focused ultrasound waves, guided by magnetic resonance imaging are used to safely ablate targeted tissue, ensuring a high rate of effectiveness with minimal side effects.|
|Israeli-based company develops a new technology for rehabilitation following stroke and other neurological impairments as well as orthopedic injuries. The device, Intuitive Neuro-Motion Learning™, design to offer a viable cost-effective solution for post stroke “Home Users” patients, and patients suffering from other Neurological/orthopedic Disorders.|
|Talshir Medical Technologies
|Talshir Medical Technologies, founded in 2009, is the global owner and marketer of Revitalvision focuses on neural vision enhancement. It is the only FDA approved therapy for adult amblyopia, which is the number one cause for unilateral impaired vision until the age of 40, with prevalence of 2%-5% of the world adult population.|
|Emedgene is the world’s first completely automated genetic interpretation platform. We’re applying the most advanced AI technologies in order to dramatically scale genetic interpretation and discovery.|
For final Schedule kindly contact: